WEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million

Bulletin Express03-30

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback conducted on 30 March 2026 under its existing mandate.

• Transaction details: The company repurchased 4.69 million H-shares on the Hong Kong Stock Exchange, paying an aggregate HKD 17.94 million. The highest and lowest prices were HKD 3.93 and HKD 3.78 per share, with a volume-weighted average cost of HKD 3.8262 per share.

• Capital structure impact: Issued shares outstanding (excluding treasury shares) declined by 0.10% to 4.48 billion. Treasury shares increased to 46.27 million, equivalent to roughly 1.02% of total issued shares, while total issued shares remained unchanged at 4.52 billion.

• Mandate utilisation: The buyback forms part of the repurchase mandate approved on 27 May 2025, which authorises the company to repurchase up to 451.56 million shares. Cumulative repurchases under this mandate now total 39.62 million shares, representing 8.77% of the authorised limit.

• Moratorium: In accordance with Hong Kong listing rules, WEIGAO GROUP is restricted from issuing new shares or disposing of treasury shares until 30 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109270669?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 17:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109270669","market":"hk","top_or_hot":-1,"title":"WEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback conducted on 30 March 2026 under its existing mandate.</p>\n<p>• Transaction details: The company repurchased 4.69 million H-shares on the Hong Kong Stock Exchange, paying an aggregate HKD 17.94 million. The highest and lowest prices were HKD 3.93 and HKD 3.78 per share, with a volume-weighted average cost of HKD 3.8262 per share.</p>\n<p>• Capital structure impact: Issued shares outstanding (excluding treasury shares) declined by 0.10% to 4.48 billion. Treasury shares increased to 46.27 million, equivalent to roughly 1.02% of total issued shares, while total issued shares remained unchanged at 4.52 billion.</p>\n<p>• Mandate utilisation: The buyback forms part of the repurchase mandate approved on 27 May 2025, which authorises the company to repurchase up to 451.56 million shares. Cumulative repurchases under this mandate now total 39.62 million shares, representing 8.77% of the authorised limit.</p>\n<p>• Moratorium: In accordance with Hong Kong listing rules, WEIGAO GROUP is restricted from issuing new shares or disposing of treasury shares until 30 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-30 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback conducted on 30 March 2026 under its existing mandate.</p>\n<p>• Transaction details: The company repurchased 4.69 million H-shares on the Hong Kong Stock Exchange, paying an aggregate HKD 17.94 million. The highest and lowest prices were HKD 3.93 and HKD 3.78 per share, with a volume-weighted average cost of HKD 3.8262 per share.</p>\n<p>• Capital structure impact: Issued shares outstanding (excluding treasury shares) declined by 0.10% to 4.48 billion. Treasury shares increased to 46.27 million, equivalent to roughly 1.02% of total issued shares, while total issued shares remained unchanged at 4.52 billion.</p>\n<p>• Mandate utilisation: The buyback forms part of the repurchase mandate approved on 27 May 2025, which authorises the company to repurchase up to 451.56 million shares. Cumulative repurchases under this mandate now total 39.62 million shares, representing 8.77% of the authorised limit.</p>\n<p>• Moratorium: In accordance with Hong Kong listing rules, WEIGAO GROUP is restricted from issuing new shares or disposing of treasury shares until 30 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1109270669","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109270669","pubTimestamp":1774863903,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback conducted on 30 March 2026 under its existing mandate. • Transaction details: The company repurchased...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团回购469万H股库存股升至4627万","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share buyback conducted on 30 March 2026 under its existing mandate.\n• Transaction details: The company repurchased 4.69 million H-shares on the Hong Kong Stock Exchange, paying an aggregate HKD 17.94 million. The highest and lowest prices were HKD 3.93 and HKD 3.78 per share, with a volume-weighted average cost of HKD 3.8262 per share.\n• Capital structure impact: Issued shares outstanding (excluding treasury shares) declined by 0.10% to 4.48 billion. Treasury shares increased to 46.27 million, equivalent to roughly 1.02% of total issued shares, while total issued shares remained unchanged at 4.52 billion.\n• Mandate utilisation: The buyback forms part of the repurchase mandate approved on 27 May 2025, which authorises the company to repurchase up to 451.56 million shares. Cumulative repurchases under this mandate now total 39.62 million shares, representing 8.77% of the authorised limit.\n• Moratorium: In accordance with Hong Kong listing rules, WEIGAO GROUP is restricted from issuing new shares or disposing of treasury shares until 30 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109270669","isCrawlerRequest":true}